Side-Chain Modification

A side-chain modification is any covalent group attached to a residue's side chain rather than to the backbone or a terminus; the residue keeps its position; only what hangs off it changes. Lysine's epsilon-amino group is the usual attachment point, being nucleophilic and easy to protect selectively; cysteine thiols and hydroxyls are the others. In the site's notation the group sits in parentheses after the residue and is footnoted beneath the sequence block.

Semaglutide's lysine at position 26 in GLP-1 numbering carries a gamma-glutamate spacer and two short PEG units ending in an 18-carbon diacid, and lysine 34 was changed to arginine so that only one lysine remained to acylate. The 31-residue backbone weighs about 3,400 daltons; the side-chain group adds roughly 716 more to reach the drug's 4,114. CJC-1295's maleimide linker, PEG chains, glycans and phosphate are written the same way.

It is distinct from a substitution, which replaces the residue, and from a terminal cap, which changes an end. A substitution changes a residue mass by a fixed amount; a side-chain group adds its own mass and chemistry, and can be installed in the wrong place, since any residue of the same type is a candidate. Regioisomers acylated at the wrong lysine are a characteristic impurity of these drugs.

Two products can share every residue and differ entirely in the group on one side chain, and since that group is usually why the drug works, backbone identity means little. Semaglutide's backbone without its side chain has a half-life of hours, not a week; the molecular weight on a certificate gives it away, roughly 3,400 against 4,114, and a listing quoting the drug's name with the backbone's mass has described the modification away.